Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Substance Abuse|July 2, 2021
Stigmatization of medications for opioid use disorder in 12-step support groups and participant responsesBarbara Andraka-Christou, Rachel Totaram, Olivia Randall-Kosich
The American Journal on Addictions|August 23, 2022
Comprehensive analysis of discharge reasons from methadone outpatient treatment programsBarbara Andraka-Christou, Rachel Totaram, Thuy D Nguyen
Current Addiction Reports|March 31, 2017
Psychiatric Co-Morbidities in Pregnant Women with Opioid Use Disorders: Prevalence, Impact, and Implications for TreatmentCamila L Arnaudo, Barbara Andraka-Christou, Kacy Allgood
JAMA Network Open|December 3, 2019
Comparison of Rural vs Urban Direct-to-Physician Commercial Promotion of Medications for Treating Opioid Use DisorderThuy Nguyen, Barbara Andraka-Christou, Kosali Simon, et al.
Journal of Substance Abuse Treatment|January 19, 2020
Assessing the impact of drug courts on provider-directed marketing efforts by manufactures of medications for the treatment of opioid use disorderBarbara Andraka-Christou, Thuy Nguyen, David W Bradford, et al.
Journal of Substance Abuse Treatment|August 3, 2019
Court personnel attitudes towards medication-assisted treatment: A state-wide surveyBarbara Andraka-Christou, Meghan Gabriel, Jody Madeira, et al.
Substance Use & Misuse|July 18, 2023
Problem-Solving Court Staff Preferences for Educational Videos about Medications for Opioid Use DisorderBarbara Andraka-Christou, Yara M Asi, Rachel Totaram, et al.
Journal of Addiction Medicine|October 20, 2021
Opting into the Public List of DATA-Waivered Practitioners: Variations by Specialty, Treatment Capacity, and Practitioner CharacteristicsThuy Nguyen, Barbara Andraka-Christou, W David Bradford, et al.
Journal of Substance Abuse Treatment|August 3, 2019
Provider-directed marketing may increase prescribing of medications for opioid use disorderThuy Nguyen, Barbara Andraka-Christou, Kosali Simon, et al.
Pageof 8